Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome

Completed · Phase 1 · Has a placebo group

Conditions studied: Interstitial Cystitis/Bladder Pain Syndrome

In brief

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with interstitial cystitis/bladder pain syndrome, compared to placebo.

Key facts

Study ID
NCT06285214
Run by
Imbrium Therapeutics
People needed
47
Starts
2022-05-26
Expected to finish
2025-01-28
Last updated by the study team
2026-03-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.